S

Synthaverse SA
WSE:SVE

Watchlist Manager
Synthaverse SA
WSE:SVE
Watchlist
Price: 4.14 PLN -2.47% Market Closed
Market Cap: 293m PLN
Have any thoughts about
Synthaverse SA?
Write Note

Synthaverse SA
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Synthaverse SA
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Synthaverse SA
WSE:SVE
Other Liabilities
zł73m
CAGR 3-Years
44%
CAGR 5-Years
25%
CAGR 10-Years
8%
M
Mabion SA
WSE:MAB
Other Liabilities
zł7.1m
CAGR 3-Years
-49%
CAGR 5-Years
-30%
CAGR 10-Years
-14%
R
Read Gene SA
WSE:RDG
Other Liabilities
zł9.6m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
3%
G
Genomed SA
WSE:GEN
Other Liabilities
zł81k
CAGR 3-Years
142%
CAGR 5-Years
70%
CAGR 10-Years
N/A
B
Bioton SA
WSE:BIO
Other Liabilities
zł39.2m
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
U
Urteste SA
WSE:URT
Other Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Synthaverse SA
Glance View

Market Cap
292m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 234 full-time employees. The company went IPO on 2011-07-29. The firm focuses on the production of drugs in the field of immunotherapy. Synthaverse SA offers its services in the field such as: oncological immunotherapy, Immunotherapy in Serological Conflict, Passive immunotherapy in hepatitis B, Active anti-tuberculosis immunotherapy, Gynecology and Proctology, Probiotics, Laboratory reagents. The firm offers injection drugs, lyophilisates of active substances in sterile sealed vials, active substances and drugs based on surface and submerged biological culture, suppository forms of drugs. The firm supplies its products to 50 countries around the world.

SVE Intrinsic Value
6.96 PLN
Undervaluation 40%
Intrinsic Value
Price
S

See Also

What is Synthaverse SA's Other Liabilities?
Other Liabilities
73m PLN

Based on the financial report for Jun 30, 2024, Synthaverse SA's Other Liabilities amounts to 73m PLN.

What is Synthaverse SA's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
8%

Over the last year, the Other Liabilities growth was 73%. The average annual Other Liabilities growth rates for Synthaverse SA have been 44% over the past three years , 25% over the past five years , and 8% over the past ten years .

Back to Top